Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

June 30, 2021 Lung Cancer in Italy - In Italian: Dr. Marina Garissino and Dr. Silvia Novello
In this special Italian-language edition of Lung Cancer Considered, host Dr. Alfredo Addeo examines lung cancer in Italy with Dr. Marina Garissino and Dr. Silvia Novello. The researchers discuss their thoughts on navigating a career as women oncologists in Italy and compare their perceptions about the differences in lung cancer screening and research between Italy and other countries.
56 min
June 15, 2021 Financial Toxicity with Dr. Fumiko Chino
In this edition of Lung Cancer Considered, host Narjust Duma and Dr. Fumiko Chino discuss a challenge to thoracic oncology which is financial toxicity associated with cancer care. The two women dive into the complexity of health insurance and the multifactorial situations that are associated with the care a patient receives. Dr. Chino also reveals her personal experience with financial toxicity and a cancer diagnosis of a family member.
41 min
June 10, 2021 ASCO 2021 Highlights with Dr. Heather Wakelee and Dr. Alfredo Addeo
The American Society of Clinical Oncology meeting just concluded and Lung Cancer Considered has a summary of the meeting, with a unique lung cancer focus. Tune in as host Stephen Liu and guests Dr. Alfredo Addeo and Dr. Heather Wakelee discuss key findings from ASCO 2021.
54 min
June 07, 2021 Neoadjuvant IO with Patrick Forde and Leah Backhus
In this edition of Lung Cancer Considered, host Dr. Narjust Duma discusses the use of neoadjuvant immunotherapy, through a multidisciplinary lens, with guests Dr. Leah Backhus and Dr. Patrick Forde.
40 min
June 01, 2021 FDA with Dr. Harpreet Singh
In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how new drug approvals are handled in other countries
38 min
May 17, 2021 Virtual Tumor Board: NSCLC - Higgins and Calles
In this episode of Lung Cancer Considered, guests Dr. Kristin A. Higgins and Dr. Antonio Calles discuss the case of a 42-year-old woman who presents to the emergency room with right shoulder pain and a dry cough that has worsened over the previous two months. A CT scan reveals she has a four-centimeter mass in her right lobe. Her PDL-1 is 1-2 percent. She has a limited history of smoking but no co-morbidities but she has lost 10 pounds since she was first seen in the emergency room.
47 min
May 11, 2021 Seminal Trials Series - KEYNOTE 001 with Dr Edward Garon and Cary Parton: Patient Input
This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients with lung cancer. This podcast is noteworthy because, in addition to including researcher Dr. Eddie Garon, it also features the unique perspective from Cary Parton, a patient who participated in this trial.
48 min
May 03, 2021 KRAS G12C Mutation with Dr. Tetsuya Mitsudomi
This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.
34 min
April 19, 2021 Tumor Board Discussion: Mesothelioma - Nowak and Mansfield
The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board in mesothelioma, involving a case with a 68-year-old male, with 30 pack years smoking history who presents to the ER due to a worsening shortness of breath at rest and with exertion, unresectable mesothelioma with chest wall invasion and pleural effusion thickening with enlarged mediastinal lymph nodes and right chest wall invasion. Thoracentesis revealed a serosanguineous fluid (removed 1.1 l) with improvement of the respiratory symptoms. Cytology was negative for malignancy. Thoracoscopy is done to obtain pleural biopsies. Listen as guests Dr. Aaron Mansfield and Dr. Anna Nowak discuss the case and offer treatment options.
46 min
April 12, 2021 Breakthrough Therapies - ALK with Dr. Ignatius Ou
In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examining MET amplifications and MET mutations. The visit helped spur him to become more involved in lung cancer research.
40 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.